In lung cancer, resistance to platinum-based chemotherapeutics can, in part, be explained through modulation of DNA repair pathways and cell cycle arrest by lncRNAs such as HOTAIR and MEG3. This evidence concerns the gene HOTAIR and lung carcinoma.